Online Iclusig (Ponatinib) Tablets
Generic name : Ponatinib.
Trade name : Iclusig.
Manufacturer information :
Iclusig is manufactured by Ariad Pharmaceuticals, Inc.
Iclusig FDA Approval:
Iclusig first approved December 14th, 2012.
Iclusig Dosage form :
Tablets: 15 mg and 45 mg.
Iclusig Indications and Usage :
Chronic Myeloid Leukemia
Indicated for patients with chronic, accelerated, or blast phase T315I-positive chronic myeloid leukemia (CML) for whom no other TKI therapy is indicated.
Iclusig (Ponatinib) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.